Literature DB >> 11136766

Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

M B Isa1, L Martínez, M Giordano, M Zapata, C Passeggi, M C De Wolff, S Nates.   

Abstract

A total of 154 human serum samples (32 acute-phase and 22 convalescent-phase serum samples obtained within a week and between days 8 and 26 after the onset of rash, respectively, and 100 samples drawn from healthy immune adults) were processed by an immunofluorescence assay for the detection of immunoglobulin M (IgM), total immunoglobulin G (IgG), IgG1, IgG2, IgG3, and IgG4 measles virus-specific antibodies. In the acute phase, IgG1 was seen first, followed by IgG2, IgG3, and IgG4 responses, the mean seropositivity of which gradually increased during convalescence, reaching 100% (standard deviation [SD], 84 to 100%), 57% (SD, 34 to 80%), 86% (SD, 66 to 100%), and 86% (SD, 66 to 100%), respectively. IgG2 rose and fell in connection with IgG3 subclass antibodies, showing a rate of detection of IgG2 and/or IgG3 subclass antibodies of 95.5% (range, 100 to 86.5%) in the convalescent phase of infection. The mean percentage of measles IgG2 and IgG3 seropositivity dropped significantly during the memory phase, to 2% (range, 2 to 6%) and 3% (range, 3 to 7%), respectively (P < 0.05); meanwhile IgG1 and IgG4 subclass responses remained relatively unmodified in samples obtained years after infection (mean 100% [SD, 96 to 100%] and 86% [SD, 79 to 93%], respectively). Results obtained defined two highly different immune isotypic response patterns. One pattern is restrictive to IgG2 and/or IgG3 in the convalescent phase and is kinetically similar to the IgM antibody response, so its detection could be referred to as a recent viral activity. On the other hand, IgG1 and IgG4 were detected in both the convalescent and memory phases of the immune response, but their isolated occurrence without IgG2 and IgG3 could be related to the long-lasting immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136766      PMCID: PMC87697          DOI: 10.1128/JCM.39.1.170-174.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Comparison of immunofluorescence and enzyme immunoassay for detection of measles-specific immunoglobulin M antibody.

Authors:  E Rossier; H Miller; B McCulloch; L Sullivan; K Ward
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells.

Authors:  B A de Boer; Y C Kruize; M Yazdanbakhsh
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.

Authors:  C K Gupta; J Leszczynski; R K Gupta; G R Siber
Journal:  Biologicals       Date:  1996-06       Impact factor: 1.856

4.  Direct evidence that gamma 1 and gamma 3 switching in human B cells is interleukin-10 dependent.

Authors:  S Fujieda; A Saxon; K Zhang
Journal:  Mol Immunol       Date:  1996-12       Impact factor: 4.407

Review 5.  Principles of measles control.

Authors:  F T Cutts; R H Henderson; C J Clements; R T Chen; P A Patriarca
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

6.  Measles virus-specific immunoglobulin G subclass response in serum and cerebrospinal fluid.

Authors:  M Narita; S Yamada; Y Matsuzono; O Itakura; T Togashi; H Kikuta
Journal:  Clin Diagn Virol       Date:  1997-11

7.  Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

Authors:  J Punnonen; G Aversa; B G Cocks; A N McKenzie; S Menon; G Zurawski; R de Waal Malefyt; J E de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Immunoglobulin G subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections.

Authors:  T Mathiesen; C Brattström; J Andersson; A Linde; P Ljungman; B Wahren
Journal:  J Med Virol       Date:  1992-01       Impact factor: 2.327

9.  Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.

Authors:  F Brière; C Servet-Delprat; J M Bridon; J M Saint-Remy; J Banchereau
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes.

Authors:  F Malisan; F Brière; J M Bridon; N Harindranath; F C Mills; E E Max; J Banchereau; H Martinez-Valdez
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  4 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.

Authors:  María Beatríz Isa; Laura Martínez; Miguel Giordano; Carlos Passeggi; María Cristina de Wolff; Silvia Nates
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 3.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

4.  Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein.

Authors:  Heather L Torrey; Valarmathy Kaliaperumal; Yogesh Bramhecha; Genevieve M Weir; Ann R Falsey; Edward E Walsh; Joanne M Langley; Bert Schepens; Xavier Saelens; Marianne M Stanford
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.